These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16793911)

  • 1. Paneth cells: leukocyte-like mediators of innate immunity in the intestine.
    Keshav S
    J Leukoc Biol; 2006 Sep; 80(3):500-8. PubMed ID: 16793911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Events at the host-microbial interface of the gastrointestinal tract. V. Paneth cell alpha-defensins in intestinal host defense.
    Bevins CL
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G173-6. PubMed ID: 16014978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paneth cells and the innate immune response.
    Wehkamp J; Stange EF
    Curr Opin Gastroenterol; 2006 Nov; 22(6):644-50. PubMed ID: 17053443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paneth cell defensins: key effector molecules of innate immunity.
    Bevins CL
    Biochem Soc Trans; 2006 Apr; 34(Pt 2):263-6. PubMed ID: 16545089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Natural immunologic function of Paneth cells in small intestine of patients with Crohn's disease].
    Maemoto A
    Hokkaido Igaku Zasshi; 2004 Mar; 79(2):129-36. PubMed ID: 15101188
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of Paneth cells and their antimicrobial peptides in innate host defense.
    Ayabe T; Ashida T; Kohgo Y; Kono T
    Trends Microbiol; 2004 Aug; 12(8):394-8. PubMed ID: 15276616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.
    Wehkamp J; Stange EF
    Ann N Y Acad Sci; 2006 Aug; 1072():321-31. PubMed ID: 17057212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
    Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
    Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link?
    Grimm MC; Pavli P
    Gut; 2004 Nov; 53(11):1558-60. PubMed ID: 15479670
    [No Abstract]   [Full Text] [Related]  

  • 10. Defensin-mediated innate immunity in the small intestine.
    Ouellette AJ
    Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):405-19. PubMed ID: 15123078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-microbe interaction: mechanisms of defensin deficiency in Crohn's disease.
    Wang G; Stange EF; Wehkamp J
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):1049-57. PubMed ID: 18039087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate defenses of the intestinal epithelial barrier.
    Müller CA; Autenrieth IB; Peschel A
    Cell Mol Life Sci; 2005 Jun; 62(12):1297-307. PubMed ID: 15971105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
    Peyrin-Biroulet L; Chamaillard M
    J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues.
    Wehkamp J; Chu H; Shen B; Feathers RW; Kays RJ; Lee SK; Bevins CL
    FEBS Lett; 2006 Oct; 580(22):5344-50. PubMed ID: 16989824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defensin-immunology in inflammatory bowel disease.
    Wehkamp J; Stange EF; Fellermann K
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD2 mutation and mice: no Crohn's disease but many lessons to learn.
    Wehkamp J; Stange EF
    Trends Mol Med; 2005 Jul; 11(7):307-9. PubMed ID: 15955743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
    Tan G; Zeng B; Zhi FC
    Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of microbiota by antimicrobial peptides in the gut.
    Masuda K; Nakamura K; Yoshioka S; Fukaya R; Sakai N; Ayabe T
    Adv Otorhinolaryngol; 2011; 72():97-9. PubMed ID: 21865701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immune defenses in the intestinal tract.
    Dann SM; Eckmann L
    Curr Opin Gastroenterol; 2007 Mar; 23(2):115-20. PubMed ID: 17268238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.